Publications by authors named "Kim Allcott"

Claim this Profile
I
Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?
Xavier Leleu, Francesca Gay, Anne Flament, Kim Allcott, Michel Delforge

Ann Hematol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic literature review of the efficacy, effectiveness, and safety of filgrastim.
David C Dale, Jeffrey Crawford, Zandra Klippel, Maureen Reiner, Timothy Osslund, Kim Allcott

Support Care Cancer· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness and safety of same-day versus next-day administration of long-acting granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced neutropenia: a systematic review.
Gary H Lyman, Kim Allcott, Jacob Garcia, Scott Stryker, Yanli Li

Support Care Cancer· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review of published Phase 3 data on anti-PCSK9 monoclonal antibodies in patients with hypercholesterolaemia.
Ioanna Gouni-Berthold, Olivier S Descamps, Uwe Fraass, Elizabeth Hartfield, Kim Allcott

Br J Clin Pharmacol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review.
Alena M Pfeil, Kim Allcott, Ruth Pettengell, Gunter von Minckwitz, Matthias Schwenkglenks

Support Care Cancer· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis